FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

672111000001100: Aprinox 2.5mg tablets (Sovereign Medical) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16255101000001110 Aprinox 2.5mg tablets (Sovereign Medical) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
111510401000001119 Aprinox 2.5mg tablets (Advanz Pharma) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aprinox 2.5mg tablets (Sovereign Medical) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Aprinox 2.5mg tablets (Sovereign Medical) Is a Product containing precisely bendroflumethiazide 2.5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Aprinox 2.5mg tablets (Sovereign Medical) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Aprinox 2.5mg tablets (Sovereign Medical) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Aprinox 2.5mg tablets (Sovereign Medical) Has excipient Lactose false Inferred relationship Existential restriction modifier
Aprinox 2.5mg tablets (Sovereign Medical) Has active ingredient Bendroflumethiazide false Inferred relationship Existential restriction modifier
Aprinox 2.5mg tablets (Sovereign Medical) Has active ingredient Bendrofluazide - chemical false Inferred relationship Existential restriction modifier
Aprinox 2.5mg tablets (Sovereign Medical) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Aprinox 2.5mg tablets (Sovereign Medical) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Aprinox 2.5mg tablets (Sovereign Medical) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Aprinox 2.5mg tablets (Sovereign Medical) Is a Aprinox true Inferred relationship Existential restriction modifier
Aprinox 2.5mg tablets (Sovereign Medical) Has specific active ingredient Bendroflumethiazide true Inferred relationship Existential restriction modifier
Aprinox 2.5mg tablets (Sovereign Medical) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Aprinox 2.5mg tablets (Sovereign Medical) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Aprinox 2.5mg tablets (Sovereign Medical) 500 tablet Is pack of False Aprinox 2.5mg tablets (Sovereign Medical) Inferred relationship Existential restriction modifier
Aprinox 2.5mg tablets (Sovereign Medical) 500 tablet Has AMP True Aprinox 2.5mg tablets (Sovereign Medical) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start